Search research articles
Contact Us
Filters
Showing results (181-190 of 207) with videos related to
Page
of 21
Sort By:
American Heart Journal
|
March 31, 1999
Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease
B R Winkelmann, A P Russ, M Nauck, et al.
Antiviral Research
|
January 15, 2018
Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells
Huanle Luo, Evandro R Winkelmann, Ildefonso Fernandez-Salas, et al.
European Heart Journal
|
August 30, 2025
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-Difference trial
Ulf Landmesser, Ulrich Laufs, Ulrike Schatz, et al.
Journal of Integrative Medicine
|
December 11, 2019
Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial
Gerli E G Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, et al.
American Heart Journal
|
April 8, 2003
Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study
Elizabeth R Hauser, Vincent Mooser, David C Crossman, et al.
Melanoma Research
|
March 7, 2022
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging
Oliver J Wisco, Justin W Marson, Graham H Litchman, et al.
NPJ Vaccines
|
December 10, 2019
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
Guangyu Li, Awadalkareem Adam, Huanle Luo, et al.
Dermatologic Clinics
|
September 10, 2017
Integrating Skin Cancer-Related Technologies into Clinical Practice
Richard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
Heart (British Cardiac Society)
|
May 22, 2021
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
Gilles R Dagenais, Leanne Dyal, Jacqueline J Bosch, et al.
Lancet (London, England)
|
January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
Guillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 207) with videos related to
Sort By:
Page
of 21
American Heart Journal
|
March 31, 1999
Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease
B R Winkelmann, A P Russ, M Nauck, et al.
Antiviral Research
|
January 15, 2018
Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells
Huanle Luo, Evandro R Winkelmann, Ildefonso Fernandez-Salas, et al.
European Heart Journal
|
August 30, 2025
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-Difference trial
Ulf Landmesser, Ulrich Laufs, Ulrike Schatz, et al.
Journal of Integrative Medicine
|
December 11, 2019
Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial
Gerli E G Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, et al.
American Heart Journal
|
April 8, 2003
Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study
Elizabeth R Hauser, Vincent Mooser, David C Crossman, et al.
Melanoma Research
|
March 7, 2022
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging
Oliver J Wisco, Justin W Marson, Graham H Litchman, et al.
NPJ Vaccines
|
December 10, 2019
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
Guangyu Li, Awadalkareem Adam, Huanle Luo, et al.
Dermatologic Clinics
|
September 10, 2017
Integrating Skin Cancer-Related Technologies into Clinical Practice
Richard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
Heart (British Cardiac Society)
|
May 22, 2021
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
Gilles R Dagenais, Leanne Dyal, Jacqueline J Bosch, et al.
Lancet (London, England)
|
January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
Guillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
Page
of 21